“Progress in gene editing allows us to envision a future where all genetic diseases are treatable and, eventually, curable. The excitement of this modality lies in its potential to be completely transformative for patients.” Read more about Arbor’s upcoming plans, our unique approach to next-generation gene editing-based therapeutics, and what to look for in the industry from our CEO Devyn Smith’s latest Q&A in Cell & Gene Therapy Insights: https://lnkd.in/gjuZfike
Arbor Biotechnologies
Biotechnology Research
Cambridge, Massachusetts 12,306 followers
Genetic medicines for genetic diseases
About us
Arbor Bio is a next-generation gene editing company focused on discovering and developing potentially curative genomic medicines, with the most extensive toolbox of proprietary genomic editors in the industry. We have the unique ability to work backward from disease pathology and choose the optimal editors or combination of editors for the disease in question.
- Website
-
http://www.arbor.bio
External link for Arbor Biotechnologies
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Cambridge, Massachusetts
- Type
- Privately Held
- Founded
- 2016
- Specialties
- Biotechnology, Discovery Science, DNA Sequencing, DNA Synthesis, CRISPR, Bioengineering, Computer Science, Molecular Biology, Machine Learning, Biochemistry, Protein Biology, and Gene Editing
Locations
-
Primary
20 Acorn Park Dr
Tower 500
Cambridge, Massachusetts 02140, US
Employees at Arbor Biotechnologies
Updates
-
We’re excited to unite with patients like Mayah and the wider PH1 community at this year’s Oxalosis and Hyperoxaluria Foundation #PatientandFamilySummit as we work together to support and raise awareness about this disease. #RareDisease #Hyperoxaluria #Oxalosis #PH1
-
Thank you to The ALS Association for having us at the Ride to Defeat ALS! Together, over $300,000 was raised to go towards #research and care for #ALS patients. A big thank you to our arboriders and everyone who donated. Together, we can truly make a difference in the lives of those affected by ALS! #ArborCares #RareDisease #IceBucket10
-
Wishing a happy arborversary to our team members! #WorkatArbor
-
Our arboriders are getting ready for this weekend’s Ride to Defeat ALS! Hear from our team co-leaders, Andy Gao & Ibrahim Al'Abri on why they ride and join us on Saturday at The ALS Association’s Ride to Defeat ALS. #ArborCares #RareDisease #ALS
-
Happy Hispanic Heritage Month! This month and beyond, we honor the cultures and contributions of Hispanic and Latinx Americans. Join us as we celebrate and learn more about the diverse heritage and history of the many countries that make up this exceptional community. #ArborAware #HispanicHeritageMonth
-
Did you know every 90-minutes, someone is diagnosed with #ALS, and someone passes away from it? We’re riding to change those odds. Join us as we Ride to Defeat ALS on September 28th! 🚲 Visit The ALS Association or link in the comments to learn more about how you can get involved. #ArborCares #RareDisease #IceBucket10
-
Earlier this year, we presented key data demonstrating the broad potential of our #geneediting technology platform and supporting the clinical development of our lead program, ABO-101, as an investigational therapy for #primaryhyperoxaluria. Chief Scientific Officer John Murphy reflects on our recent suite of data presented at #ASGCT and comments on current trends within the gene editing field.
Data in Review: Expanding the Therapeutic Application of Gene Editing Tools
Arbor Biotechnologies on LinkedIn
-
Class is in session! 🎒 ✏ We had a great time participating in The Wonderfund’s Impact Back to School Drive supporting the MA Department of Children & Families. Checkout the great work The Wonderfund does and how you can get involved. #ArborGiving #BacktoSchool
-
Wishing a Happy Arborversary to our team members! #WorkatArbor